Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

TELOTELO
Showing 8 of 9 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in TELOMIR PHARMACEUTICALS INC

Bank of New York Mellon Corp holds 51,454 shares of TELO (TELOMIR PHARMACEUTICALS INC), worth $65,861 as of 2026-Q2.

Current Value

$65,861

Current Shares

51,454

Total Value Change

-$263,896

Total Shares Change

+90

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
51,454
0.0%
$65,8610.0%$1.28
0
2026-Q1
Unchanged
51,454
0.0%
$66,8900.0%$1.30
0
2025-Q4
Unchanged
51,454
0.0%
$68,4340.0%$1.34
0
2025-Q3
Increased
51,454
0.0%
$71,5210.0%$1.34
14
2025-Q2
Decreased
51,453
-43.7%
$64,3160.0%$1.53
0
2025-Q1
Increased
91,353
+26.4%
$295,0700.0%$3.95
29
2024-Q4
Increased
72,295
+40.8%
$297,8560.0%$4.64
31
2024-Q3
Increased
51,364
+2.4%
$329,7570.0%$6.82
24

Other major holders of TELO: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used